Comment on: Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study.

Clin Drug Investig

Zydus Research Centre, a Division of Cadila Healthcare Ltd, Sarkhej-Bavla NH 8A, Moraiya, Ahmedabad, Gujarat, 382 210, India.

Published: January 2019

Download full-text PDF	Source
http://dx.doi.org/10.1007/s40261-018-0738-x	DOI Listing

Publication Analysis

comment pharmacokinetics

pharmacokinetics pharmacodynamics

pharmacodynamics safety

safety novel

novel calcimimetic

calcimimetic agent

agent evocalcet

evocalcet healthy

healthy japanese

japanese subjects

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!